# HTR3A

## Overview
The HTR3A gene encodes the 5-hydroxytryptamine receptor 3A (5-HT3A), a subunit of the serotonin type 3 receptor, which is a ligand-gated ion channel. This receptor is part of the Cys-loop receptor family and is unique among serotonin receptors due to its ion channel formation, as opposed to being G protein-coupled (Barnes2009The). The 5-HT3A subunit can form homomeric receptors and is involved in fast synaptic transmission, playing a crucial role in neuronal depolarization and excitation (Barnes2020International). The receptor is expressed in various brain regions and peripheral tissues, indicating its broad role in modulating serotonin signaling across different body systems (Niesler2008Serotonin). The HTR3A gene is located on chromosome 11 and undergoes alternative splicing, resulting in different isoforms that influence receptor function and response to agonists and modulators (Barnes2009The). Variants of the HTR3A gene have been associated with several psychiatric and gastrointestinal disorders, highlighting its clinical significance (Celli2016The).

## Structure
The HTR3A gene encodes the 5-HT3A receptor, a cation-selective ligand-gated ion channel within the Cys-loop receptor family. The primary structure of the 5-HT3A subunit includes a predicted signal peptide of 23 residues, with the polypeptide ranging between 478 and 490 amino acids in length, showing high sequence conservation (83-87% identity) (Barnes2009The). The secondary structure features a large extracellular N-terminal domain, four transmembrane domains (M1-M4), and a large intracellular loop between M3 and M4. The M2 domain lines the ion conduction pathway, while M1, M3, and M4 surround it (Livesey2008Structural; Barnes2009The). The MA-helix within the intracellular loop contributes to ion permeation (Barnes2009The).

The tertiary structure involves the arrangement of these domains to form a functional ion channel. The quaternary structure is a pentameric assembly of subunits that form the receptor, with the 5-HT3A subunit capable of forming homopentamers (Livesey2008Structural; Barnes2009The). The human HTR3A gene is located on chromosome 11 and comprises 9 exons and 8 introns. Alternative splicing results in different isoforms, such as the 'long' (5-HT3A(a)) and 'short' (5-HT3A(b)) isoforms, which differ in the intracellular loop length and show different responses to receptor agonists and modulators (Barnes2009The). Common post-translational modifications include N-glycosylation, which is crucial for receptor formation and export from the endoplasmic reticulum (Barnes2009The).

## Function
The HTR3A gene encodes the 5-HT3A subunit, which is a component of the serotonin type 3 (5-HT3) receptor, a ligand-gated ion channel. This receptor is unique among serotonin receptors as it forms an ion channel rather than being G protein-coupled. The 5-HT3A subunit can form functional homomeric receptors and is involved in fast synaptic transmission by mediating neuronal depolarization and excitation (Barnes2020International; Barnes2009The). 

In healthy human cells, 5-HT3 receptors play significant roles in cognition and emotion, including learning and anxiety control. They are also crucial in regulating gastrointestinal functions such as emesis, gut motility, visceral perception, and secretion (Niesler20115HT3). The 5-HT3A subunit is expressed in various brain regions, including the frontal cortex, amygdala, and hippocampus, as well as in peripheral tissues, indicating its broad role in modulating serotonin signaling across different body systems (Barnes2009The; Niesler2008Serotonin).

The receptor's function is influenced by its subunit composition, which affects ion permeation and selectivity. The 5-HT3A subunit allows permeability to both monovalent and divalent cations, contributing to its role in neurotransmission (Barnes2009The).

## Clinical Significance
Mutations and alterations in the HTR3A gene, which encodes the 5-HT3A receptor, have been implicated in various psychiatric and gastrointestinal disorders. Variants such as c.-42C>T are associated with bipolar affective disorder (BPAD), schizophrenia, and major depression. This SNP is located in a regulatory region and increases the expression of 5-HT3A receptor subunits, potentially affecting receptor density on the cell surface (Celli2016The). The c.-42C>T variant is also linked to irritable bowel syndrome with diarrhea (IBS-D) and gastroesophageal reflux disease (GERD), possibly due to its impact on receptor expression levels (Walstab20105-HT3).

In schizophrenia, rare missense mutations such as p.R344H and p.P391R have been identified, although their functional impact remains unclear (Walstab20105-HT3). The c.1377A>G SNP is associated with a three-fold increased risk of postoperative nausea and vomiting (PONV) (Celli2016The). The HTR3A gene is also implicated in the pathophysiology of autism spectrum disorders, with the intronic variant rs1150220 showing significant association (Walstab20105-HT3).

The gene's polymorphisms are linked to individual drug responses, influencing therapeutic outcomes in conditions like schizophrenia and major depression (Walstab20105-HT3). These findings highlight the clinical significance of HTR3A in various complex conditions.

## Interactions
The HTR3A gene encodes the 5-HT3A receptor, which is part of the serotonin receptor family and forms ligand-gated ion channels. The 5-HT3A receptor can form functional homomeric channels on its own or heteromeric channels when co-expressed with the 5-HT3B subunit. The 5-HT3B subunit requires co-expression with 5-HT3A to exit the endoplasmic reticulum and form functional receptors (Barnes2009The).

The 5-HT3A receptor interacts with the chaperone protein RIC-3, which modulates its functional surface expression. This interaction is mediated by a specific 24-amino acid segment within the intracellular domain (ICD) of the 5-HT3A receptor, particularly the L1-MX region (Pirayesh2019Delineating). The presence of the M3M4 loop in the 5-HT3A receptor influences its interaction with RIC-3, as truncation of this loop significantly attenuates the interaction (Jansen2008Modular).

The 5-HT3A receptor also forms clusters in F-actin-rich regions, and its internalization is likely mediated by clathrin-coated endosomes (Barnes2009The). These interactions highlight the receptor's role in neurotransmission and its regulation by various proteins.


## References


[1. (Niesler20115HT3) Beate Niesler. 5-ht3 receptors: potential of individual isoforms for personalised therapy. Current Opinion in Pharmacology, 11(1):81–86, February 2011. URL: http://dx.doi.org/10.1016/j.coph.2011.01.011, doi:10.1016/j.coph.2011.01.011. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.coph.2011.01.011)

[2. (Barnes2009The) Nicholas M. Barnes, Tim G. Hales, Sarah C.R. Lummis, and John A. Peters. The 5-ht3 receptor – the relationship between structure and function. Neuropharmacology, 56(1):273–284, January 2009. URL: http://dx.doi.org/10.1016/j.neuropharm.2008.08.003, doi:10.1016/j.neuropharm.2008.08.003. This article has 307 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuropharm.2008.08.003)

3. (Pirayesh2019Delineating) Delineating the site of interaction on the intracellular domain of 5-HT3A receptors with the chaperone protein RIC-3. This article has 0 citations.

[4. (Celli2016The) Jacopo Celli, Gudrun Rappold, and Beate Niesler. The human serotonin type 3 receptor gene (htr3a-e) allelic variant database: human mutation. Human Mutation, 38(2):137–147, November 2016. URL: http://dx.doi.org/10.1002/humu.23136, doi:10.1002/humu.23136. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23136)

[5. (Livesey2008Structural) Matthew R. Livesey, Michelle A. Cooper, Tarek Z. Deeb, Jane E. Carland, Janna Kozuska, Tim. G. Hales, Jeremy J. Lambert, and John A. Peters. Structural determinants of ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3a receptor. Journal of Biological Chemistry, 283(28):19301–19313, July 2008. URL: http://dx.doi.org/10.1074/jbc.m802406200, doi:10.1074/jbc.m802406200. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m802406200)

[6. (Niesler2008Serotonin) Beate Niesler, Johannes Kapeller, Christian Hammer, and Gudrun Rappold. Serotonin type 3 receptor genes: htr3a, b, c, d, e. Pharmacogenomics, 9(5):501–504, May 2008. URL: http://dx.doi.org/10.2217/14622416.9.5.501, doi:10.2217/14622416.9.5.501. This article has 64 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/14622416.9.5.501)

[7. (Barnes2020International) Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts, and Daniel Hoyer. International union of basic and clinical pharmacology. cx. classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacological Reviews, 73(1):310–520, December 2020. URL: http://dx.doi.org/10.1124/pr.118.015552, doi:10.1124/pr.118.015552. This article has 158 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.118.015552)

[8. (Jansen2008Modular) Michaela Jansen, Moez Bali, and Myles H. Akabas. Modular design of cys-loop ligand-gated ion channels: functional 5-ht3 and gaba ρ1 receptors lacking the large cytoplasmic m3m4 loop. The Journal of General Physiology, 131(2):137–146, January 2008. URL: http://dx.doi.org/10.1085/jgp.200709896, doi:10.1085/jgp.200709896. This article has 101 citations.](https://doi.org/10.1085/jgp.200709896)

[9. (Walstab20105-HT3) Jutta Walstab, Gudrun Rappold, and Beate Niesler. 5-ht3 receptors: role in disease and target of drugs. Pharmacology &amp; Therapeutics, 128(1):146–169, October 2010. URL: http://dx.doi.org/10.1016/j.pharmthera.2010.07.001, doi:10.1016/j.pharmthera.2010.07.001. This article has 250 citations.](https://doi.org/10.1016/j.pharmthera.2010.07.001)